| Literature DB >> 27681182 |
Qing-Qin Yin1, Hai-Can Liu2, Wei-Wei Jiao1, Qin-Jing Li1, Rui Han1, Jian-Ling Tian1, Zhi-Guang Liu2, Xiu-Qin Zhao2, Ying-Jia Li1, Kang-Lin Wan2, A-Dong Shen1, Igor Mokrousov3.
Abstract
Mycobacterium tuberculosis Beijing genotype originated in China and has undergone a dramatic population growth and global spread in the last century. Here, a collection of M. tuberculosis Beijing family isolates from different provinces across all China was genotyped by high-resolution (24-MIRU-VNTR) and low-resolution, high-rank (modern and ancient sublineages) markers. The molecular profiles and global and local phylogenies were compared to the strain phenotype and patient data. The phylogeographic patterns observed in the studied collection demonstrate that large-scale (but not middle/small-scale) distance remains one of the decisive factors of the genetic divergence of M. tuberculosis populations. Analysis of diversity and network topology of the local collections appears to corroborate a recent intriguing hypothesis about Beijing genotype originating in South China. Placing our results within the Eurasian context suggested that important Russian B0/W148 and Asian/Russian A0/94-32 epidemic clones of the Beijing genotype could trace their origins to the northeastern and northwestern regions of China, respectively. The higher clustering of the modern isolates in children and lack of increased MDR rate in any sublineage suggest that not association with drug resistance but other (e.g., speculatively, virulence-related) properties underlie an enhanced dissemination of the evolutionarily recent, modern sublineage of the Beijing genotype in China.Entities:
Year: 2016 PMID: 27681182 PMCID: PMC5041183 DOI: 10.1038/srep34353
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Evolutionary scenario of the M. tuberculosis Beijing genotype.
Modified from Ribeiro et al.12 (Copyright © 2014, American Society for Microbiology) and complemented with additional information on B0/W148 strain (Mokrousov, 2013) and modern Beijing sublineage4.
Epidemiological and clinical characteristics of patients and M. tuberculosis strains.
| Characteristics | Early ancient (N = 33) n(%) | Ancient (N = 104) n(%) | Modern (N = 216) n(%) |
|---|---|---|---|
| Gender | |||
| Female | 15 (45.5) | 42 (41.2) | 90 (42.9) |
| Male | 18 (54.5) | 60 (58.8) | 120 (57.1) |
| unknown | 0 | 2 | 6 |
| Age (years) | |||
| ≦18 | 20 (60.6) | 54 (51.9) | 134 (62.0) |
| >18 | 13 (39.4) | 50 (48.1) | 82 (38.0) |
| Treatment history | |||
| New cases | 18 (58.1) | 63 (62.4) | 143 (66.2) |
| Previously treated cases | 13 (41.9) | 38 (37.6) | 65 (30.8) |
| unknown | 2 | 3 | 8 |
| Geographic distribution | |||
| Northern | 22 (66.7) | 32 (31.4) | 113 (54.1) |
| Central | 6 (18.2) | 18 (17.6) | 50 (23.9) |
| Southern | 5 (15.2) | 20 (19.6) | 28 (13.4) |
| X.-Uyghur | 0 | 3 (2.9) | 5 (2.4) |
| Tibet | 0 | 29 (28.4) | 13 (6.2) |
| unknown | 0 | 2 | 7 |
Strains with available designation of either of 3 sublineages, early ancient, ancient and modern (defined by RD181, mutT2 and muT4 alleles [Fig. 1]).
Central: Anhui, Chongqing, Henan, Jiangsu, Shaanxi, Sichuan.
Northern: Beijing, Gansu, Hebei, Qinghai, Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shandong, Shanxi, Tianjin.
Southern: Fujian, Guangxi, Guizhou, Hainan, Jiangxi.
Figure 2Geographic distribution of the Beijing family sublineages in five geographical regions in mainland China.
Circle size is proportional to the number of isolates. Beijing+ and Gansu+ mean Beijing, Gansu and their neighboring provinces. Free map of China: http://www.freeworldmaps.net/asia/china/pdf/china_pol.pdf.
Figure 3Local populations of the Beijing family in the selected regions/provinces: phylogeny, cumulative index of diversity, and other measures of diversity.
Free map of China: http://www.freeworldmaps.net/asia/china/pdf/china_pol.pdf.
Figure 4Cumulative index of diversity of Beijing genotype populations plotted against distance from Guizhou (~South China, a hypothesized place of origin of the Beijing genotype).
An arrow shows a corrected position of Tibet due to mountain barriers of human migration. Exact values are shown in Supporting Table S2.
Drug resistance properties of sublineages of the Beijing genotype.
| Drug-resistant type | Early ancient (N = 32) n (%) | Ancient (N = 103) n (%) | Modern (N = 214) n (%) |
|---|---|---|---|
| Sensitive | 16 (50.0) | 43 (41.7) | 101 (47.4) |
| Any resistance (incl. MDR) | 16 (50.0) | 60 (58.3) | 113 (52.8) |
| MDR | 8 (24.2) | 32 (25.6) | 55 (25.6) |
Drug resistance in main clonal complexes (defined by combination of SLV and starness) and large single types.
| Genotype, clonal complex and its position in MST ( | Resistant to 2 and more drugs, N and % of all in this CC | Susceptible and monoresistant, N and % of all in this CC | Total |
|---|---|---|---|
| Modern | |||
| CC-6 supercluster | 48 (44%) | 62 (56%) | 110 |
| CC-6 core | 28 (44%) | 36 (56%) | 64 |
| | |||
| CC-1 distal (relative to CC-6) | 11 (65%) | 6 (35%) | 17 |
| | |||
| CC-11 distal (relative to CC-6) | 6 (37%) | 10 (63%) | 16 |
| CC-14 distal (relative to CC-6) | 3 (23%) | 10 (77%) | 13 |
| CC-18 supercluster | 42 (49%) | 44 (51%) | 86 |
| | |||
| | |||
| Ancient | |||
| CC-29 core | 5 (23%) | 17 (77%) | 22 |
| CC-27/28 outlier | 4 (33%) | 8 (67%) | 12 |
| CC-A derived distal (relative to CC-29) | 1 (12%) | 7 (88%) | 8 |
| CC-B intermediate, derived from CC-29 | 4 (67%) | 2 (33%) | 6 |
| CC-C derived from CC-29 | 2 (33%) | 4 (67%) | 6 |
| CC-D derived from CC-29 | 5 (100%) | 0 | 5 |
| Early ancient | |||
| CC-32 | 4 (50%) | 4 (50%) | 8 |
Number of clonal complexes (CC) is not consecutive; it is defined by the number of its central type. Data in columns are not additive since some superclusters and CC include large types.